Blood thinner for extra heartbeats and stroke risk
Part of Heart & circulation clinical trials.
This study tests a blood thinner (rivaroxaban) versus usual care to see if it can prevent strokes in older adults with extra heartbeats (a sign of possible heart rhythm problems) and high stroke risk. If you qualify, the treatment might reduce your chances of having a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 65 years old.
- You need to have many extra heartbeats or short bursts of fast heartbeats (called 'PACs') seen on a 24-hour heart monitor (Holter).
- You must have a high risk of stroke, which your doctor can check with a score.
- You should not have other conditions that raise bleeding risk or require another blood thinner.
- You need to be able to have an MRI brain scan now and at 2 years, and attend study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two doses of rivaroxaban (15mg and 20mg) to see how well they prevent strokes in people with non-valvular atrial fibrillation, a type of irregular heartbeat not caused by a heart valve problem. It may be an option if you need blood thinners to lower your stroke risk.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This trial tests whether a lower dose of the blood thinner rivaroxaban works as well as the standard dose for people 70 and older with atrial fibrillation (an irregular heartbeat). The goal is to find the safest dose to prevent strokes while reducing bleeding risks.
This trial compares two medicines to prevent blood clots after heart valve surgery. If you've had a tissue valve replaced or repaired, this study will see if a newer blood thinner (rivaroxaban) is safer and works better than the standard treatment.
This trial tests how to use a blood thinner in people after a recent heart attack who have a clot in the left heart chamber confirmed by heart MRI. It may help lower the risk of the clot causing serious complications, but it also requires careful bleeding-safety screening.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
Hear when a new Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.